Cheshire, UK – 28 April 2025 – BlackfinBio Ltd, a clinical stage gene therapy company focused on the development of treatments for rare neurological diseases, announces today that the U.S. Food and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback